BIOMAT Database Logo BIOMAT Database Logo

[Clinical experience with dibekacin (DKB) intravenous drip in the field of thoracic surgery (author's transl)]. 1978

M Nakabayashi, and N Yamazaki, and T Ito

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003982 Dibekacin Analog of KANAMYCIN with antitubercular as well as broad-spectrum antimicrobial properties. Dideoxykanamycin B,3',4'-Dideoxykanamycin B,Dibekacin Sulfate,Dibekacin Sulphate,Dideoxykanamycine,Orbicin,3',4' Dideoxykanamycin B,B, 3',4'-Dideoxykanamycin,Sulfate, Dibekacin,Sulphate, Dibekacin
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Nakabayashi, and N Yamazaki, and T Ito
[Dibekacin blood concentration following intravenous drip infusion (author's transl)].
May 1979, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Blood levels of dibekacin following intravenous drip infusion (author's transl)].
September 1977, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Clinical experience with minocycline by intravenous drip (author's transl)].
April 1979, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Experience with intravenous drip infusion of amikacin in urological field (author's transl)].
February 1981, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Experience with intravenous drip infusion of amikacin (author's transl)].
July 1981, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Experience of amikacin intravenous drip infusion (author's transl)].
July 1980, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Fundamental and clinical studies on intravenous drip infusion of dibekacin in the pediatric field].
August 1985, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Studies on the antigenicity of dibekacin (DKB), an aminoglycoside antibiotic, eye drops (author's transl)].
September 1981, Nippon Ganka Gakkai zasshi,
M Nakabayashi, and N Yamazaki, and T Ito
The intravenous toxicity of dibekacin sulphate (DKB) to female beagle dogs.
August 1980, The Japanese journal of antibiotics,
M Nakabayashi, and N Yamazaki, and T Ito
[Application of minocycline for intravenous drip in urological field (author's transl)].
June 1974, The Japanese journal of antibiotics,
Copied contents to your clipboard!